全体要約
製品とサービスのセグメントでは、消耗品と試薬が最大のシェアを占めています。2022年のデータによれば、消耗品と試薬は市場で最大のシェアを獲得しました。技術セグメントでは、マイクロアレイ技術が最低の成長を示しています。地域別では、北米に次いでヨーロッパが第二の市場であり、広範な開発や業界間の連携が市場成長を促進すると見込まれています。主要なゲノミクス市場のプレイヤーには、Illumina、Thermo Fisher Scientific、Danaher、QIAGEN、Agilent Technologies、PerkinElmer、F. Hoffmann-La Rocheが含まれます。
関連する質問
83.1 billion USD (2028年)
12.4% (2023年から2028年)
Illumina, Inc., Thermo Fisher Scientific, Inc., Danaher Corporation, QIAGEN N.V., Agilent Technologies, Inc., PerkinElmer Inc., F. Hoffmann-La Roche Ltd.
政府によるゲノミクスプロジェクトへの資金提供の増加, ウイルス病や遺伝的障害の発生率と有病率の上昇, がんの発生率の増加とがん研究における次世代シーケンシングの応用の増加
概要
消耗品および試薬は、製品およびサービスセグメントで最も大きなシェアを占めると予想されています。
製品およびサービスに基づいて、ゲノミクス市場は消耗品と試薬、サービス、機器、システム、およびソフトウェアにセグメント化されています。2022年には、消耗品と試薬のセグメントがゲノミクス市場の最大のシェアを占めました。診断、パーソナライズドメディスン、創薬、動物研究などのさまざまな分野におけるゲノミクスの応用の増加は、予測期間中に消耗品と試薬の市場を促進すると期待されています。
マイクロアレイセグメントは、ゲノミクス市場における技術セグメントの中で最も低い市場成長を占めました。
技術に基づいて、ゲノミクス市場はシーケンシング、PCR、マイクロアレイ、フローサイトメトリー、その他の技術に分かれています。2022年には、マイクロアレイ技術が最も低い市場成長を占めました。マイクロアレイ技術は、遺伝子発見、疾病診断、薬剤発見、癌研究、毒物研究に応用されています。しかし、シーケンシング技術の採用が増加することで、この市場の成長はある程度制限されるでしょう。
ヨーロッパはゲノミクス市場で2番目に大きな地域です。
ゲノミクス市場は北米、ヨーロッパ、アジア太平洋、ラテンアメリカ（LATAM）、中東およびアフリカ（MEA）にセグメント化されています。北米に次いで、ヨーロッパでは、ゲノミクスの大規模な発展、NGSベースの診断テストの導入、業界プレーヤーと研究機関との協力が、地域の市場成長を促進すると予測されています。
この報告書のために実施された主なインタビューは、以下のように分類できます：
• 回答者別：供給側 80%、需要側 20%
• 職位別: マネージャー - 45%、CXO及びディレクター級 - 30%、エグゼクティブ - 25%
地域別：北米 -30%、欧州 -20%、アジア太平洋 -35%、ラテンアメリカ -10%、中東およびアフリカ -5%
ゲノミクス市場の主要企業には、イルミナ社（米国）、サーモフィッシャーサイエンティフィック社（米国）、ダナハー社（米国）、QIAGEN N.V.（ドイツ）、アジャイルントテクノロジーズ社（米国）、パーキンエルマー社（米国）、F. ホフマン・ラ・ロシュ社（スイス）が含まれます。
研究カバレッジ：
この報告書は、ゲノミクス市場の詳細な状況を提供します。市場の製品、アプリケーション、技術、研究タイプ、エンドユーザー、地域などのさまざまなセグメントにわたる規模と将来の成長可能性を推定することを目的としています。また、主要市場プレーヤーの競争分析と、彼らの企業プロフィール、最近の開発、主要な市場戦略も含まれています。
報告書購入の主な利点：
この報告書は、業界のリーダーや新規参入者に、全体のゲノミクス市場およびそのサブセグメントの収益数字に最も近い近似値を提供することで助けることができます。また、利害関係者が競争環境をよりよく理解し、自社のポジショニングを改善し、適切な市場進出戦略を策定するための洞察を得るのにも役立ちます。この報告書は、利害関係者が市場の動向を把握し、主要な市場推進要因、制約、課題、トレンド、機会に関する情報を提供することを可能にします。
報告書は以下のポイントに関する洞察を提供します：
• 主な推進要因の分析（ゲノミクスプロジェクトを支援するための政府の資金増加、ウイルス性疾患および遺伝性疾患の発生率および有病率の上昇、がんの発生率増加およびがん研究における次世代シーケンシングの利用増加、ゲノミクススタートアップへの堅実な投資、ゲノミクスの利用の増加）、機会（専門的/個別化医療におけるゲノミクスの利用）、課題（倫理的問題、訓練を受けた専門家の不足、大量データの安全な保管）、トレンド（ゲノミクスにおける技術進歩のためのパートナーシップと協力、ゲノミクスにおけるAI）がゲノミクス市場の成長に影響を与えています。
• 製品およびサービスの開発/革新：新たに展開された製品やサービスに関する詳細な洞察と、ゲノム市場の技術評価。
• 市場開発：収益性の高い市場に関する包括的な情報 – レポートは、さまざまな地域にわたるゲノム市場を分析しています。
• 市場の多様化: ジェノミクス市場における新しい製品やサービス、未開拓の地域、最近の動向、投資に関する詳細な情報です。
• 競争評価：Illumina, Inc.（アメリカ）、Thermo Fisher Scientific, Inc.（アメリカ）、Danaher Corporation（アメリカ）、QIAGEN N.V.（ドイツ）、Agilent Technologies, Inc.（アメリカ）、PerkinElmer Inc.（アメリカ）、F. Hoffmann-La Roche Ltd.（スイス）などの主要企業の市場シェア、成長戦略、サービス提供についての詳細な評価を行います。このレポートは、利害関係者がゲノム市場の動向を理解し、主要な市場ドライバー、抑制要因、課題、および機会についての情報を提供します。
※以下の目次にて、具体的なレポートの構成をご覧頂けます。ご購入、無料サンプルご請求、その他お問い合わせは、ページ上のボタンよりお進みください。
目次
1 イントロダクション 34
1.1 調査の目的 34
1.2 市場の定義 35
1.2.1 包含・除外事項 35
1.3 市場範囲 36
1.3.1 対象市場 36
1.3.2 対象年 37
1.4 通貨 37
1.5 制約 37
1.6 ステークホルダー 38
1.7 変化のサマリー 38
2 調査手法 39
2.1 調査アプローチ 39
2.1.1 一次調査 40
2.2 市場予測手法 41
2.2.1 一次エキスパート考察 43
2.3 市場成長率予測 44
2.4 データのトライアンギュレーション 47
2.5 調査の前提 48
2.6 リスク分析 48
2.7 リセッション時のインパクト 49
3 エグゼクティブサマリー 51
4 更なる考察 55
4.1 ゲノム市場の概要 55
4.2 北米のゲノミクス市場：製品・サービス別、国別（2022年） 56
4.3 ゲノム市場シェア、用途別 2023年 vs. 2028年 57
4.4 ゲノム市場 地域における成長機会 57
5 市場概要 58
5.1 イントロダクション 58
5.2 市場力学 58
5.2.1 促進要因 60
5.2.2 市場機会 63
- 5.2.2.1 専門・個別化医療におけるゲノミクスの活用 63
5.2.3 課題 64
- 5.2.3.1 倫理的問題 64
- 5.2.3.2 訓練されたプロフェッショナルの不足 64
- 5.2.3.3 大量のシーケンサーデータを安全に保管 64
5.2.4 トレンド 65
- 5.2.4.1 ゲノミクスの技術的進歩のためのパートナーシップと共同研究 65
- 5.2.4.2 ゲノミクス向けAI 66
5.3 技術分析 67
5.4 バリューチェーン分析 69
5.5 規制分析 69
5.5.1 北米 69
- 5.5.1.1 米国 69
- 5.5.1.2 カナダ 71
5.5.2 ヨーロッパ 71
5.5.3 アジア太平洋 72
- 5.5.3.1 中国 72
- 5.5.3.2 日本 72
- 5.5.3.3 インド 73
5.5.4 ラテンアメリカ 73
5.5.5 中東 73
5.6 ゲノミクス市場のエコシステム分析 74
5.7 顧客ビジネスに影響を与えるトレンド/ディスラプション 74
5.8 価格分析 75
5.8.1 NGS製品の平均販売価格 75
5.8.2 PCR製品の平均販売価格 75
5.8.3 平均販売価格トレンド分析 76
5.9 2023-2024年の主な会議・イベント 76
5.10 ポーターのファイブフォース分析 77
5.10.1 新規参入の脅威 78
5.10.2 代替品の脅威 78
5.10.3 サプライヤーの交渉力 78
5.10.4 買い手の交渉力 78
5.10.5 競合・競争状況の激しさ 78
5.11 特許分析 79
5.12 主なステークホルダーと購入基準 82
6 ゲノム市場、製品・サービス別 84
6.1 イントロダクション 85
6.2 消耗品・試薬 85
6.2.1 様々な分野でのゲノミクス応用の拡大が採用を促進 85
6.3 サービス 88
6.4 機器・システム・ソフトウェア 91
6.4.1 市場成長を支える技術的進歩 91
7 ゲノムの市場、技術別 95
7.1 イントロダクション 96
7.2 シーケンシング 96
7.3 PCR 99
7.3.1 PCR技術のドラッグディスカバリーへの活用が市場を促進 99
7.4 フローサイトメトリー 102
7.4.1 アグリゲノミクスにおけるフローサイトメトリーの応用が市場成長を支える 102
7.5 マイクロアレイ 104
7.5.1 NGSの導入が進み、マイクロアレイ技術の成長が制限 104
7.6 その他の技術 106
8 ゲノムの市場、用途別 109
8.1 イントロダクション 110
8.2 ドラッグディスカバリーと現像剤 110
8.2.1 ゲノミクス市場の最大のアプリケーションセグメント 110
8.3 診断 113
8.3.1 診断分野でのゲノミクス応用の拡大が市場を促進 113
8.4 農業と動物研究 117
8.4.1 農作物や家畜の生産性向上に貢献するゲノミクス 117
8.5 その他の用途 119
9 ゲノミクス市場：研究タイプ別 122
9.1 イントロダクション 123
9.2 ファンクショナルゲノミクス 123
9.2.1 ゲノム研究の進展が市場成長に好影響を与える 123
9.3 バイオマーカー探索 126
9.3.1 個別化医療の進展が市場成長を支える 126
9.4 パスウェイ解析 128
9.4.1 次世代治療薬の開発が市場を牽引 128
9.5 エピジェノミクス 131
9.5.1 エピジェネティクス研究への投資拡大が市場成長を支える 131
9.6 その他のスタディタイプ 133
10 ゲノムの市場、エンドユーザー別 136
10.1 イントロダクション 137
10.2 病院・クリニック 137
10.2.1 疾病診断・治療への応用拡大が市場を牽引 137
10.3 アカデミック・研究機関 140
10.4 製薬・バイオ企業 143
10.5 その他のエンドユーザー 145
11 ゲノムの市場、地域別 148
11.1 イントロダクション 149
11.2 北米 149
11.2.1 米国 153
- 11.2.1.1 北米のゲノミクス市場は米国が独占 153
11.2.2 カナダ 157
- 11.2.2.1 ゲノミクス研究の進展が市場を牽引 157
11.2.3 北米：リセッション時のインパクト 160
11.3 ヨーロッパ 160
11.3.1 ドイツ 164
- 11.3.1.1 NGSの認知度向上が市場成長を後押し 164
11.3.2 英国 166
11.3.3 フランス 170
- 11.3.3.1 ゲノミクスへの政府投資の増加が市場を牽引 170
11.3.4 イタリア 172
- 11.3.4.1 有利な資金調達シナリオがシーケンサー技術の採用を促進 172
11.3.5 スペイン 175
- 11.3.5.1 ゲノム研究の拡大に注力し、市場成長を支える 175
11.3.6 その他ヨーロッパ 178
11.3.7 ヨーロッパ：リセッション時のインパクト 181
11.4 アジア太平洋 181
11.4.1 中国 186
- 11.4.1.1 アジア太平洋地域で急成長している市場 186
11.4.2 日本 188
- 11.4.2.1 成長するNGS市場が市場成長を支える 188
11.4.3 インド 191
11.4.4 オーストラリア 194
11.4.5 韓国 196
- 11.4.5.1 市場成長を後押しする政府の取り組み 196
11.4.6 その他アジア太平洋 199
11.4.7 アジア太平洋：リセッション時のインパクト 201
11.5 ラテンアメリカ 202
11.5.1 キープレーヤーの拡大が市場成長を促進 202
11.5.2 ラテンアメリカ：リセッション時のインパクト 204
11.6 中東・アフリカ 205
12 競合情勢 209
12.1 イントロダクション 209
12.2 主要プレイヤーの戦略 210
12.3 収益分析 211
12.4 市場シェア分析 212
12.5 企業評価マトリックス 214
12.5.1 STARS 214
12.5.2 EMERGING LEADERS 214
12.5.3 PERVASIVE PLAYERS 214
12.5.4 PARTICIPANTS 214
12.6 競合ベンチマーキング 216
12.6.1 企業フットプリント（32社） 216
12.6.2 各社の製品・サービスのフットプリント（32社） 217
12.6.3 企業の地域フットプリント（32社） 218
12.7 STARTUPS/SMESの企業評価マトリクス 220
12.7.1 PROGRESSIVE COMPANIES 220
12.7.2 STARTING BLOCKS 220
12.7.3 RESPONSIVE COMPANIES 220
12.7.4 DYNAMIC COMPANIES 220
12.8 STARTUPS/SMESの競合ベンチマーキング 222
12.9 COMPETITIVE SCENARIO AND TRENDS 223
12.9.1 製品・サービスの立ち上げ 223
12.9.2 ディール 224
12.9.3 その他の展開 225
13 企業プロファイル 226
13.1 主要企業 226
13.1.1 ILLUMINA, INC. 226
13.1.2 THERMO FISHER SCIENTIFIC INC. 242
13.1.3 F. HOFFMANN-LA ROCHE LTD. 258
13.1.4 DANAHER CORPORATION 267
13.1.5 QIAGEN N.V. 273
13.1.6 AGILENT TECHNOLOGIES, INC. 282
13.1.7 PERKINELMER INC. 294
13.1.8 BIO-RAD LABORATORIES, INC. 300
13.1.9 EUROFINS SCIENTIFIC 306
13.1.10 PACIFIC BIOSCIENCES 310
13.1.11 OXFORD NANOPORE TECHNOLOGIES PLC 317
13.1.12 TAKARA BIO INC. 325
13.1.13 BGI GROUP 333
13.1.14 EPPENDORF AG 342
13.1.15 MERCK KGAA 345
13.1.16 BECTON, DICKINSON AND COMPANY 350
13.1.17 ABBOTT LABORATORIES 356
13.1.18 23ANDME, INC. 361
13.1.19 10X GENOMICS 364
13.1.20 NEW ENGLAND BIOLABS 369
13.1.21 PROMEGA CORPORATION 374
13.1.22 CREATIVE BIOGENE 380
13.1.23 NOVOGENE CO., LTD. 384
13.1.24 ULTIMA GENOMICS, INC. 386
13.1.25 FREENOME HOLDINGS, INC. 387
13.2 他の有力企業 389
13.2.1 QUEST DIAGNOSTICS 389
13.2.2 MYRIAD GENETICS, INC. 390
13.2.3 PERSONALIS, INC. 391
13.2.4 HELIX OPCO, LLC 392
13.2.5 POLARIS GENOMICS 392
13.2.6 PHALANX BIOTECH GROUP 393
13.2.7 GENOMIQA PTY LTD 393
14 付録 394
14.1 ディスカッションガイド 394
14.2 ナレッジストア 399
14.3 カスタマイズオプション 401
14.4 関連レポート 402
14.5 執筆者の詳細 403
※英文のレポートについての日本語表記のタイトルや紹介文などは、すべて生成AIや自動翻訳ソフトを使用して提供しております。それらはお客様の便宜のために提供するものであり、当社はその内容について責任を負いかねますので、何卒ご了承ください。適宜英語の原文をご参照ください。
“All Japanese titles, abstracts, and other descriptions of English-language reports were created using generative AI and/or machine translation. These are provided for your convenience only and may contain errors and inaccuracies. Please be sure to refer to the original English-language text. We disclaim all liability in relation to your reliance on such AI-generated and/or machine-translated content.”
Description
Table of Contents
1 INTRODUCTION 34
1.1 STUDY OBJECTIVES 34
1.2 MARKET DEFINITION 35
1.2.1 INCLUSIONS AND EXCLUSIONS 35
1.3 MARKET SCOPE 36
1.3.1 MARKETS COVERED 36
1.3.2 YEARS CONSIDERED 37
1.4 CURRENCY 37
1.5 LIMITATIONS 37
1.6 STAKEHOLDERS 38
1.7 SUMMARY OF CHANGES 38
2 RESEARCH METHODOLOGY 39
2.1 RESEARCH APPROACH 39
2.1.1 PRIMARY RESEARCH 40
2.2 MARKET ESTIMATION METHODOLOGY 41
2.2.1 INSIGHTS FROM PRIMARY EXPERTS 43
2.3 MARKET GROWTH RATE PROJECTIONS 44
2.4 DATA TRIANGULATION 47
2.5 RESEARCH ASSUMPTIONS 48
2.6 RISK ANALYSIS 48
2.7 RECESSION IMPACT 49
3 EXECUTIVE SUMMARY 51
4 PREMIUM INSIGHTS 55
4.1 GENOMICS MARKET OVERVIEW 55
4.2 NORTH AMERICA: GENOMICS MARKET, BY PRODUCT & SERVICE AND COUNTRY (2022) 56
4.3 GENOMICS MARKET SHARE, BY APPLICATION, 2023 VS. 2028 57
4.4 GENOMICS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 57
5 MARKET OVERVIEW 58
5.1 INTRODUCTION 58
5.2 MARKET DYNAMICS 58
5.2.1 DRIVERS 60
- 5.2.1.1 Increasing government funding to support genomics projects 60
- 5.2.1.2 Rising incidence and prevalence of viral diseases and genetic disorders 60
- 5.2.1.3 Growing incidence of cancer and increasing applications of next-generation sequencing in cancer research 61
- 5.2.1.4 Robust investments in genomics startups 62
- 5.2.1.5 Growing applications of genomics 63
5.2.2 OPPORTUNITIES 63
- 5.2.2.1 Use of genomics in specialized/personalized medicine 63
5.2.3 CHALLENGES 64
- 5.2.3.1 Ethical issues 64
- 5.2.3.2 Dearth of trained professionals 64
- 5.2.3.3 Secure storage of large volumes of sequenced data 64
5.2.4 TRENDS 65
- 5.2.4.1 Partnerships and collaborations for technological advancements in genomics 65
- 5.2.4.2 AI in genomics 66
5.3 TECHNOLOGY ANALYSIS 67
5.4 VALUE CHAIN ANALYSIS 69
5.5 REGULATORY ANALYSIS 69
5.5.1 NORTH AMERICA 69
- 5.5.1.1 US 69
- 5.5.1.2 Canada 71
5.5.2 EUROPE 71
5.5.3 ASIA PACIFIC 72
- 5.5.3.1 China 72
- 5.5.3.2 Japan 72
- 5.5.3.3 India 73
5.5.4 LATIN AMERICA 73
5.5.5 MIDDLE EAST 73
5.6 ECOSYSTEM ANALYSIS OF GENOMICS MARKET 74
5.7 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 74
5.8 PRICING ANALYSIS 75
5.8.1 AVERAGE SELLING PRICE OF NGS PRODUCTS 75
5.8.2 AVERAGE SELLING PRICE OF PCR PRODUCTS 75
5.8.3 AVERAGE SELLING PRICE TREND ANALYSIS 76
5.9 KEY CONFERENCES AND EVENTS IN 2023-2024 76
5.10 PORTER’S FIVE FORCES ANALYSIS 77
5.10.1 THREAT OF NEW ENTRANTS 78
5.10.2 THREAT OF SUBSTITUTES 78
5.10.3 BARGAINING POWER OF SUPPLIERS 78
5.10.4 BARGAINING POWER OF BUYERS 78
5.10.5 INTENSITY OF COMPETITIVE RIVALRY 78
5.11 PATENT ANALYSIS 79
5.12 KEY STAKEHOLDERS AND BUYING CRITERIA 82
6 GENOMICS MARKET, BY PRODUCT & SERVICE 84
6.1 INTRODUCTION 85
6.2 CONSUMABLES AND REAGENTS 85
6.2.1 GROWING APPLICATIONS OF GENOMICS IN VARIOUS FIELDS TO DRIVE ADOPTION 85
6.3 SERVICES 88
6.3.1 LACK OF IN-HOUSE EXPERTISE FOR INTERPRETATION OF GENOMICS DATA TO BOOST MARKET FOR OUTSOURCING SERVICES 88
6.4 INSTRUMENTS, SYSTEMS, AND SOFTWARE 91
6.4.1 TECHNOLOGICAL ADVANCEMENTS TO SUPPORT MARKET GROWTH 91
7 GENOMICS MARKET, BY TECHNOLOGY 95
7.1 INTRODUCTION 96
7.2 SEQUENCING 96
7.2.1 LAUNCH OF NEW NGS PLATFORMS AND LOWER COST OF SEQUENCING TO DRIVE MARKET 96
7.3 PCR 99
7.3.1 USE OF PCR TECHNOLOGIES FOR DRUG DISCOVERY TO PROPEL MARKET 99
7.4 FLOW CYTOMETRY 102
7.4.1 APPLICATION OF FLOW CYTOMETRY IN AGRIGENOMICS TO SUPPORT MARKET GROWTH 102
7.5 MICROARRAYS 104
7.5.1 HIGH ADOPTION OF NGS TO LIMIT GROWTH OF MICROARRAY TECHNOLOGIES 104
7.6 OTHER TECHNOLOGIES 106
8 GENOMICS MARKET, BY APPLICATION 109
8.1 INTRODUCTION 110
8.2 DRUG DISCOVERY AND DEVELOPMENT 110
8.2.1 LARGEST APPLICATION SEGMENT OF GENOMICS MARKET 110
8.3 DIAGNOSTICS 113
8.3.1 GROWING APPLICATIONS OF GENOMICS IN DIAGNOSTICS FIELD TO PROPEL MARKET 113
8.4 AGRICULTURE AND ANIMAL RESEARCH 117
8.4.1 GENOMICS HELPS IMPROVE PRODUCTIVITY OF CROPS AND LIVESTOCK 117
8.5 OTHER APPLICATIONS 119
9 GENOMICS MARKET, BY STUDY TYPE 122
9.1 INTRODUCTION 123
9.2 FUNCTIONAL GENOMICS 123
9.2.1 INCREASED GENOMIC STUDIES TO POSITIVELY INFLUENCE MARKET GROWTH 123
9.3 BIOMARKER DISCOVERY 126
9.3.1 RISE IN PERSONALIZED MEDICINE TO SUPPORT MARKET GROWTH 126
9.4 PATHWAY ANALYSIS 128
9.4.1 DEVELOPMENT OF NEXT-GENERATION THERAPIES TO DRIVE MARKET 128
9.5 EPIGENOMICS 131
9.5.1 INCREASE IN INVESTMENTS FOR EPIGENETICS RESEARCH TO SUPPORT MARKET GROWTH 131
9.6 OTHER STUDY TYPES 133
10 GENOMICS MARKET, BY END USER 136
10.1 INTRODUCTION 137
10.2 HOSPITALS AND CLINICS 137
10.2.1 INCREASED APPLICATION IN DISEASE DIAGNOSIS AND TREATMENT TO DRIVE MARKET 137
10.3 ACADEMIC AND RESEARCH INSTITUTES 140
10.3.1 INCREASE IN RESEARCH INTENSITY TO DRIVE USE OF GENOMICS PRODUCTS AMONG ACADEMIC AND RESEARCH INSTITUTES 140
10.4 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES 143
10.4.1 GROWING IMPORTANCE OF BIOMARKERS FOR DRUG DISCOVERY TO DRIVE ADOPTION OF GENOMICS PRODUCTS AND SERVICES AMONG PHARMA AND BIOTECH COMPANIES 143
10.5 OTHER END USERS 145
11 GENOMICS MARKET, BY REGION 148
11.1 INTRODUCTION 149
11.2 NORTH AMERICA 149
11.2.1 US 153
- 11.2.1.1 US dominates North American genomics market 153
11.2.2 CANADA 157
- 11.2.2.1 Increasing research in genomics to drive market 157
11.2.3 NORTH AMERICA: RECESSION IMPACT 160
11.3 EUROPE 160
11.3.1 GERMANY 164
- 11.3.1.1 Increasing awareness of NGS to boost market growth 164
11.3.2 UK 166
- 11.3.2.1 Availability of government funding and strategic collaborations with biotech firms to boost market growth 166
11.3.3 FRANCE 170
- 11.3.3.1 Increasing government investments in genomics to drive market 170
11.3.4 ITALY 172
- 11.3.4.1 Favorable funding scenario to drive adoption of sequencing technologies 172
11.3.5 SPAIN 175
- 11.3.5.1 Focus on expanding genomic research to support market growth 175
11.3.6 REST OF EUROPE 178
11.3.7 EUROPE: RECESSION IMPACT 181
11.4 ASIA PACIFIC 181
11.4.1 CHINA 186
- 11.4.1.1 Fastest-growing market in Asia Pacific 186
11.4.2 JAPAN 188
- 11.4.2.1 Growing NGS market to support market growth 188
11.4.3 INDIA 191
- 11.4.3.1 Emergence of local players and increasing adoption of genomics technologies to aid market growth 191
11.4.4 AUSTRALIA 194
- 11.4.4.1 Increase in precision medicine and academic studies to propel market growth 194
11.4.5 SOUTH KOREA 196
- 11.4.5.1 Government initiatives to favor market growth 196
11.4.6 REST OF ASIA PACIFIC 199
11.4.7 ASIA PACIFIC: RECESSION IMPACT 201
11.5 LATIN AMERICA 202
11.5.1 EXPANSION OF KEY PLAYERS TO BOOST MARKET GROWTH 202
11.5.2 LATIN AMERICA: RECESSION IMPACT 204
11.6 MIDDLE EAST AND AFRICA 205
11.6.1 INCREASING ADOPTION OF GENETIC TESTING AND RISING HIV & CANCER INCIDENCE TO DRIVE MARKET 205
11.6.2 MIDDLE EAST AND AFRICA: RECESSION IMPACT 208
12 COMPETITIVE LANDSCAPE 209
12.1 INTRODUCTION 209
12.2 STRATEGIES ADOPTED BY KEY PLAYERS 210
12.3 REVENUE ANALYSIS 211
12.4 MARKET SHARE ANALYSIS 212
12.5 COMPANY EVALUATION MATRIX 214
12.5.1 STARS 214
12.5.2 EMERGING LEADERS 214
12.5.3 PERVASIVE PLAYERS 214
12.5.4 PARTICIPANTS 214
12.6 COMPETITIVE BENCHMARKING 216
12.6.1 OVERALL COMPANY FOOTPRINT (32 COMPANIES) 216
12.6.2 PRODUCT & SERVICE FOOTPRINT OF COMPANIES (32 COMPANIES) 217
12.6.3 REGIONAL FOOTPRINT OF COMPANIES (32 COMPANIES) 218
12.7 COMPANY EVALUATION MATRIX FOR STARTUPS/SMES 220
12.7.1 PROGRESSIVE COMPANIES 220
12.7.2 STARTING BLOCKS 220
12.7.3 RESPONSIVE COMPANIES 220
12.7.4 DYNAMIC COMPANIES 220
12.8 COMPETITIVE BENCHMARKING OF STARTUPS/SMES 222
12.9 COMPETITIVE SCENARIO AND TRENDS 223
12.9.1 PRODUCT/SERVICE LAUNCHES 223
12.9.2 DEALS 224
12.9.3 OTHER DEVELOPMENTS 225
13 COMPANY PROFILES 226
13.1 MAJOR PLAYERS 226
13.1.1 ILLUMINA, INC. 226
13.1.2 THERMO FISHER SCIENTIFIC INC. 242
13.1.3 F. HOFFMANN-LA ROCHE LTD. 258
13.1.4 DANAHER CORPORATION 267
13.1.5 QIAGEN N.V. 273
13.1.6 AGILENT TECHNOLOGIES, INC. 282
13.1.7 PERKINELMER INC. 294
13.1.8 BIO-RAD LABORATORIES, INC. 300
13.1.9 EUROFINS SCIENTIFIC 306
13.1.10 PACIFIC BIOSCIENCES 310
13.1.11 OXFORD NANOPORE TECHNOLOGIES PLC 317
13.1.12 TAKARA BIO INC. 325
13.1.13 BGI GROUP 333
13.1.14 EPPENDORF AG 342
13.1.15 MERCK KGAA 345
13.1.16 BECTON, DICKINSON AND COMPANY 350
13.1.17 ABBOTT LABORATORIES 356
13.1.18 23ANDME, INC. 361
13.1.19 10X GENOMICS 364
13.1.20 NEW ENGLAND BIOLABS 369
13.1.21 PROMEGA CORPORATION 374
13.1.22 CREATIVE BIOGENE 380
13.1.23 NOVOGENE CO., LTD. 384
13.1.24 ULTIMA GENOMICS, INC. 386
13.1.25 FREENOME HOLDINGS, INC. 387
13.2 OTHER PLAYERS 389
13.2.1 QUEST DIAGNOSTICS 389
13.2.2 MYRIAD GENETICS, INC. 390
13.2.3 PERSONALIS, INC. 391
13.2.4 HELIX OPCO, LLC 392
13.2.5 POLARIS GENOMICS 392
13.2.6 PHALANX BIOTECH GROUP 393
13.2.7 GENOMIQA PTY LTD 393
14 APPENDIX 394
14.1 DISCUSSION GUIDE 394
14.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 399
14.3 CUSTOMIZATION OPTIONS 401
14.4 RELATED REPORTS 402
14.5 AUTHOR DETAILS 403
TABLE 1 GLOBAL INFLATION RATE PROJECTIONS, 2021-2027 (% GROWTH) TABLE 2 US HEALTH EXPENDITURE, 2019-2022 (USD MILLION) TABLE 3 US HEALTH EXPENDITURE, 2023-2027 (USD MILLION) TABLE 4 GENOMICS MARKET: IMPACT ANALYSIS OF DRIVERS, OPPORTUNITIES, CHALLENGES, AND TRENDS TABLE 5 CANCER INCIDENCE, 2020 VS. 2040 TABLE 6 COMPARISON OF SANGER SEQUENCING AND NGS TABLE 7 COMPARISON OF PCR TECHNOLOGIES TABLE 8 US FDA: MEDICAL DEVICE CLASSIFICATION TABLE 9 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS TABLE 10 CHINA: CLASSIFICATION OF MEDICAL DEVICES TABLE 11 AVERAGE SELLING PRICE OF NGS SYSTEMS, BY KEY PLAYER (2022) TABLE 12 AVERAGE SELLING PRICE OF PCR SYSTEMS, BY KEY PLAYER (2022) TABLE 13 GENOMICS MARKET: LIST OF CONFERENCES AND EVENTS TABLE 14 GENOMICS MARKET: PORTER’S FIVE FORCES ANALYSIS TABLE 15 INDICATIVE LIST OF PATENTS IN GENOMICS (NEXT-GENERATION SEQUENCING) MARKET TABLE 16 INDICATIVE LIST OF PATENTS IN GENOMICS (POLYMERASE CHAIN REACTION) MARKET TABLE 17 GENOMICS MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION) TABLE 18 GENOMICS CONSUMABLES AND REAGENTS MARKET, BY REGION, 2021-2028 (USD MILLION) TABLE 19 NORTH AMERICA: GENOMICS CONSUMABLES AND REAGENTS MARKET, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 20 EUROPE: GENOMICS CONSUMABLES AND REAGENTS MARKET, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 21 ASIA PACIFIC: GENOMICS CONSUMABLES AND REAGENTS MARKET, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 22 GENOMICS SERVICES MARKET, BY REGION, 2021-2028 (USD MILLION) TABLE 23 NORTH AMERICA: GENOMICS SERVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 24 EUROPE: GENOMICS SERVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 25 ASIA PACIFIC: GENOMICS SERVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 26 LIST OF COMPANIES OFFERING MICROARRAY SCANNERS TABLE 27 GENOMICS INSTRUMENTS, SYSTEMS, AND SOFTWARE MARKET, BY REGION, 2021-2028 (USD MILLION) TABLE 28 NORTH AMERICA: GENOMICS INSTRUMENTS, SYSTEMS, AND SOFTWARE MARKET, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 29 EUROPE: GENOMICS INSTRUMENTS, SYSTEMS, AND SOFTWARE MARKET, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 30 ASIA PACIFIC: GENOMICS INSTRUMENTS, SYSTEMS, AND SOFTWARE MARKET, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 31 GENOMICS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION) TABLE 32 SEQUENCING MARKET, BY REGION, 2021-2028 (USD MILLION) TABLE 33 NORTH AMERICA: SEQUENCING MARKET, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 34 EUROPE: SEQUENCING MARKET, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 35 ASIA PACIFIC: SEQUENCING MARKET, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 36 PCR MARKET, BY REGION, 2021-2028 (USD MILLION) TABLE 37 NORTH AMERICA: PCR MARKET, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 38 EUROPE: PCR MARKET, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 39 ASIA PACIFIC: PCR MARKET, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 40 FLOW CYTOMETRY MARKET, BY REGION, 2021-2028 (USD MILLION) TABLE 41 NORTH AMERICA: FLOW CYTOMETRY MARKET, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 42 EUROPE: FLOW CYTOMETRY MARKET, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 43 ASIA PACIFIC: FLOW CYTOMETRY MARKET, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 44 MICROARRAYS MARKET, BY REGION, 2021-2028 (USD MILLION) TABLE 45 NORTH AMERICA: MICROARRAYS MARKET, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 46 EUROPE: MICROARRAYS MARKET, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 47 ASIA PACIFIC: MICROARRAYS MARKET, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 48 OTHER TECHNOLOGIES MARKET, BY REGION, 2021-2028 (USD MILLION) TABLE 49 NORTH AMERICA: OTHER TECHNOLOGIES MARKET, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 50 EUROPE: OTHER TECHNOLOGIES MARKET, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 51 ASIA PACIFIC: OTHER TECHNOLOGIES MARKET, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 52 GENOMICS MARKET, BY APPLICATION, 2021-2028 (USD MILLION) TABLE 53 GENOMICS MARKET FOR DRUG DISCOVERY AND DEVELOPMENT APPLICATIONS, BY REGION, 2021-2028 (USD MILLION) TABLE 54 NORTH AMERICA: GENOMICS MARKET FOR DRUG DISCOVERY AND DEVELOPMENT APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 55 EUROPE: GENOMICS MARKET FOR DRUG DISCOVERY AND DEVELOPMENT APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 56 ASIA PACIFIC: GENOMICS MARKET FOR DRUG DISCOVERY AND DEVELOPMENT APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 57 GRANTS, BY CANCER TYPE (AS OF JANUARY 2023) TABLE 58 GENOMICS MARKET FOR DIAGNOSTIC APPLICATIONS, BY REGION, 2021-2028 (USD MILLION) TABLE 59 NORTH AMERICA: GENOMICS MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 60 EUROPE: GENOMICS MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 61 ASIA PACIFIC: GENOMICS MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 62 GENOMICS MARKET FOR AGRICULTURE AND ANIMAL RESEARCH APPLICATIONS, BY REGION, 2021-2028 (USD MILLION) TABLE 63 NORTH AMERICA: GENOMICS MARKET FOR AGRICULTURE AND ANIMAL RESEARCH APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 64 EUROPE: GENOMICS MARKET FOR AGRICULTURE AND ANIMAL RESEARCH APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 65 ASIA PACIFIC: GENOMICS MARKET FOR AGRICULTURE AND ANIMAL RESEARCH APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 66 GENOMICS MARKET FOR OTHER APPLICATIONS, BY REGION, 2021-2028 (USD MILLION) TABLE 67 NORTH AMERICA: GENOMICS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 68 EUROPE: GENOMICS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 69 ASIA PACIFIC: GENOMICS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 70 GENOMICS MARKET, BY STUDY TYPE, 2021-2028 (USD MILLION) TABLE 71 GENOMICS MARKET FOR FUNCTIONAL GENOMICS, BY REGION, 2021-2028 (USD MILLION) TABLE 72 NORTH AMERICA: GENOMICS MARKET FOR FUNCTIONAL GENOMICS, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 73 EUROPE: GENOMICS MARKET FOR FUNCTIONAL GENOMICS, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 74 ASIA PACIFIC: GENOMICS MARKET FOR FUNCTIONAL GENOMICS, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 75 GENOMICS MARKET FOR BIOMARKER DISCOVERY, BY REGION, 2021-2028 (USD MILLION) TABLE 76 NORTH AMERICA: GENOMICS MARKET FOR BIOMARKER DISCOVERY, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 77 EUROPE: GENOMICS MARKET FOR BIOMARKER DISCOVERY, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 78 ASIA PACIFIC: GENOMICS MARKET FOR BIOMARKER DISCOVERY, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 79 GENOMICS MARKET FOR PATHWAY ANALYSIS, BY REGION, 2021-2028 (USD MILLION) TABLE 80 NORTH AMERICA: GENOMICS MARKET FOR PATHWAY ANALYSIS, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 81 EUROPE: GENOMICS MARKET FOR PATHWAY ANALYSIS, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 82 ASIA PACIFIC: GENOMICS MARKET FOR PATHWAY ANALYSIS, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 83 GENOMICS MARKET FOR EPIGENOMICS, BY REGION, 2021-2028 (USD MILLION) TABLE 84 NORTH AMERICA: GENOMICS MARKET FOR EPIGENOMICS, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 85 EUROPE: GENOMICS MARKET FOR EPIGENOMICS, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 86 ASIA PACIFIC: GENOMICS MARKET FOR EPIGENOMICS, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 87 GENOMICS MARKET FOR OTHER STUDY TYPES, BY REGION, 2021-2028 (USD MILLION) TABLE 88 NORTH AMERICA: GENOMICS MARKET FOR OTHER STUDY TYPES, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 89 EUROPE: GENOMICS MARKET FOR OTHER STUDY TYPES, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 90 ASIA PACIFIC: GENOMICS MARKET FOR OTHER STUDY TYPES, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 91 GENOMICS MARKET, BY END USER, 2021-2028 (USD MILLION) TABLE 92 GENOMICS MARKET FOR HOSPITALS AND CLINICS, BY REGION, 2021-2028 (USD MILLION) TABLE 93 NORTH AMERICA: GENOMICS MARKET FOR HOSPITALS AND CLINICS, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 94 EUROPE: GENOMICS MARKET FOR HOSPITALS AND CLINICS, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 95 ASIA PACIFIC: GENOMICS MARKET FOR HOSPITALS AND CLINICS, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 96 GENOMICS MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2021-2028 (USD MILLION) TABLE 97 NORTH AMERICA: GENOMICS MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 98 EUROPE: GENOMICS MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 99 ASIA PACIFIC: GENOMICS MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 100 GENOMICS MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2021-2028 (USD MILLION) TABLE 101 NORTH AMERICA: GENOMICS MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 102 EUROPE: GENOMICS MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 103 ASIA PACIFIC: GENOMICS MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 104 GENOMICS MARKET FOR OTHER END USERS, BY REGION, 2021-2028 (USD MILLION) TABLE 105 NORTH AMERICA: GENOMICS MARKET FOR OTHER END USERS, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 106 EUROPE: GENOMICS MARKET FOR OTHER END USERS, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 107 ASIA PACIFIC: GENOMICS MARKET FOR OTHER END USERS, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 108 GENOMICS MARKET, BY REGION, 2021-2028 (USD MILLION) TABLE 109 NORTH AMERICA: GENOMICS MARKET, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 110 NORTH AMERICA: GENOMICS MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION) TABLE 111 NORTH AMERICA: GENOMICS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION) TABLE 112 NORTH AMERICA: GENOMICS MARKET, BY APPLICATION, 2021-2028 (USD MILLION) TABLE 113 NORTH AMERICA: GENOMICS MARKET, BY STUDY TYPE, 2021-2028 (USD MILLION) TABLE 114 NORTH AMERICA: GENOMICS MARKET, BY END USER, 2021-2028 (USD MILLION) TABLE 115 US: GENOMICS MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION) TABLE 116 US: GENOMICS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION) TABLE 117 US: GENOMICS MARKET, BY APPLICATION, 2021-2028 (USD MILLION) TABLE 118 US: GENOMICS MARKET, BY STUDY TYPE, 2021-2028 (USD MILLION) TABLE 119 US: GENOMICS MARKET, BY END USER, 2021-2028 (USD MILLION) TABLE 120 CANADA: GENOMICS MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION) TABLE 121 CANADA: GENOMICS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION) TABLE 122 CANADA: GENOMICS MARKET, BY APPLICATION, 2021-2028 (USD MILLION) TABLE 123 CANADA: GENOMICS MARKET, BY STUDY TYPE, 2021-2028 (USD MILLION) TABLE 124 CANADA: GENOMICS MARKET, BY END USER, 2021-2028 (USD MILLION) TABLE 125 EUROPE: GENOMICS MARKET, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 126 EUROPE: GENOMICS MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION) TABLE 127 EUROPE: GENOMICS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION) TABLE 128 EUROPE: GENOMICS MARKET, BY APPLICATION, 2021-2028 (USD MILLION) TABLE 129 EUROPE: GENOMICS MARKET, BY STUDY TYPE, 2021-2028 (USD MILLION) TABLE 130 EUROPE: GENOMICS MARKET, BY END USER, 2021-2028 (USD MILLION) TABLE 131 GERMANY: GENOMICS MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION) TABLE 132 GERMANY: GENOMICS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION) TABLE 133 GERMANY: GENOMICS MARKET, BY APPLICATION, 2021-2028 (USD MILLION) TABLE 134 GERMANY: GENOMICS MARKET, BY STUDY TYPE, 2021-2028 (USD MILLION) TABLE 135 GERMANY: GENOMICS MARKET, BY END USER, 2021-2028 (USD MILLION) TABLE 136 UK: GENOMICS MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION) TABLE 137 UK: GENOMICS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION) TABLE 138 UK: GENOMICS MARKET, BY APPLICATION, 2021-2028 (USD MILLION) TABLE 139 UK: GENOMICS MARKET, BY STUDY TYPE, 2021-2028 (USD MILLION) TABLE 140 UK: GENOMICS MARKET, BY END USER, 2021-2028 (USD MILLION) TABLE 141 FRANCE: GENOMICS MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION) TABLE 142 FRANCE: GENOMICS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION) TABLE 143 FRANCE: GENOMICS MARKET, BY APPLICATION, 2021-2028 (USD MILLION) TABLE 144 FRANCE: GENOMICS MARKET, BY STUDY TYPE, 2021-2028 (USD MILLION) TABLE 145 FRANCE: GENOMICS MARKET, BY END USER, 2021-2028 (USD MILLION) TABLE 146 ITALY: GENOMICS, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION) TABLE 147 ITALY: GENOMICS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION) TABLE 148 ITALY: GENOMICS MARKET, BY APPLICATION, 2021-2028 (USD MILLION) TABLE 149 ITALY: GENOMICS MARKET, BY STUDY TYPE, 2021-2028 (USD MILLION) TABLE 150 ITALY: GENOMICS MARKET, BY END USER, 2021-2028 (USD MILLION) TABLE 151 SPAIN: GENOMICS MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION) TABLE 152 SPAIN: GENOMICS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION) TABLE 153 SPAIN: GENOMICS MARKET, BY APPLICATION, 2021-2028 (USD MILLION) TABLE 154 SPAIN: GENOMICS MARKET, BY STUDY TYPE, 2021-2028 (USD MILLION) TABLE 155 SPAIN: GENOMICS MARKET, BY END USER, 2021-2028 (USD MILLION) TABLE 156 REST OF EUROPE: GENOMICS MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION) TABLE 157 REST OF EUROPE: GENOMICS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION) TABLE 158 REST OF EUROPE: GENOMICS MARKET, BY APPLICATION, 2021-2028 (USD MILLION) TABLE 159 REST OF EUROPE: GENOMICS MARKET, BY STUDY TYPE, 2021-2028 (USD MILLION) TABLE 160 REST OF EUROPE: GENOMICS MARKET, BY END USER, 2021-2028 (USD MILLION) TABLE 161 ASIA PACIFIC: GENOMICS MARKET, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 162 ASIA PACIFIC: GENOMICS MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION) TABLE 163 ASIA PACIFIC: GENOMICS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION) TABLE 164 ASIA PACIFIC: GENOMICS MARKET, BY APPLICATION, 2021-2028 (USD MILLION) TABLE 165 ASIA PACIFIC: GENOMICS MARKET, BY STUDY TYPE, 2021-2028 (USD MILLION) TABLE 166 ASIA PACIFIC: GENOMICS MARKET, BY END USER, 2021-2028 (USD MILLION) TABLE 167 CHINA: GENOMICS MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION) TABLE 168 CHINA: GENOMICS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION) TABLE 169 CHINA: GENOMICS MARKET, BY APPLICATION, 2021-2028 (USD MILLION) TABLE 170 CHINA: GENOMICS MARKET, BY STUDY TYPE, 2021-2028 (USD MILLION) TABLE 171 CHINA: GENOMICS MARKET, BY END USER, 2021-2028 (USD MILLION) TABLE 172 JAPAN: GENOMICS MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION) TABLE 173 JAPAN: GENOMICS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION) TABLE 174 JAPAN: GENOMICS MARKET, BY APPLICATION, 2021-2028 (USD MILLION) TABLE 175 JAPAN: GENOMICS MARKET, BY STUDY TYPE, 2021-2028 (USD MILLION) TABLE 176 JAPAN: GENOMICS MARKET, BY END USER, 2021-2028 (USD MILLION) TABLE 177 INDIA: GENOMICS MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION) TABLE 178 INDIA: GENOMICS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION) TABLE 179 INDIA: GENOMICS MARKET, BY APPLICATION, 2021-2028 (USD MILLION) TABLE 180 INDIA: GENOMICS MARKET, BY STUDY TYPE, 2021-2028 (USD MILLION) TABLE 181 INDIA: GENOMICS MARKET, BY END USER, 2021-2028 (USD MILLION) TABLE 182 AUSTRALIA: GENOMICS MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION) TABLE 183 AUSTRALIA: GENOMICS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION) TABLE 184 AUSTRALIA: GENOMICS MARKET, BY APPLICATION, 2021-2028 (USD MILLION) TABLE 185 AUSTRALIA: GENOMICS MARKET, BY STUDY TYPE, 2021-2028 (USD MILLION) TABLE 186 AUSTRALIA: GENOMICS MARKET, BY END USER, 2021-2028 (USD MILLION) TABLE 187 SOUTH KOREA: GENOMICS MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION) TABLE 188 SOUTH KOREA: GENOMICS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION) TABLE 189 SOUTH KOREA: GENOMICS MARKET, BY APPLICATION, 2021-2028 (USD MILLION) TABLE 190 SOUTH KOREA: GENOMICS MARKET, BY STUDY TYPE, 2021-2028 (USD MILLION) TABLE 191 SOUTH KOREA: GENOMICS MARKET, BY END USER, 2021-2028 (USD MILLION) TABLE 192 REST OF ASIA PACIFIC: GENOMICS MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION) TABLE 193 REST OF ASIA PACIFIC: GENOMICS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION) TABLE 194 REST OF ASIA PACIFIC: GENOMICS MARKET, BY APPLICATION, 2021-2028 (USD MILLION) TABLE 195 REST OF ASIA PACIFIC: GENOMICS MARKET, BY STUDY TYPE, 2021-2028 (USD MILLION) TABLE 196 REST OF ASIA PACIFIC: GENOMICS MARKET, BY END USER, 2021-2028 (USD MILLION) TABLE 197 LATIN AMERICA: GENOMICS MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION) TABLE 198 LATIN AMERICA: GENOMICS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION) TABLE 199 LATIN AMERICA: GENOMICS MARKET, BY APPLICATION, 2021-2028 (USD MILLION) TABLE 200 LATIN AMERICA: GENOMICS MARKET, BY STUDY TYPE, 2021-2028 (USD MILLION) TABLE 201 LATIN AMERICA: GENOMICS MARKET, BY END USER, 2021-2028 (USD MILLION) TABLE 202 MIDDLE EAST AND AFRICA: GENOMICS MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION) TABLE 203 MIDDLE EAST AND AFRICA: GENOMICS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION) TABLE 204 MIDDLE EAST AND AFRICA: GENOMICS MARKET, BY APPLICATION, 2021-2028 (USD MILLION) TABLE 205 MIDDLE EAST AND AFRICA: GENOMICS MARKET, BY STUDY TYPE, 2021-2028 (USD MILLION) TABLE 206 MIDDLE EAST AND AFRICA: GENOMICS MARKET, BY END USER, 2021-2028 (USD MILLION) TABLE 207 GENOMICS MARKET: DEGREE OF COMPETITION TABLE 208 PRODUCT & SERVICE AND REGIONAL FOOTPRINT ANALYSIS OF KEY PLAYERS TABLE 209 PRODUCT & SERVICE FOOTPRINT ANALYSIS OF KEY PLAYERS TABLE 210 REGIONAL FOOTPRINT ANALYSIS OF KEY PLAYERS TABLE 211 GENOMICS MARKET: DETAILED LIST OF KEY STARTUPS/SMES TABLE 212 GENOMICS MARKET: KEY PRODUCT/SERVICE LAUNCHES, JANUARY 2020-APRIL 2023 TABLE 213 GENOMICS MARKET: KEY DEALS, JANUARY 2020-APRIL 2023 TABLE 214 GENOMICS MARKET: OTHER KEY DEVELOPMENTS, JANUARY 2020-APRIL 2023 TABLE 215 ILLUMINA, INC.: BUSINESS OVERVIEW TABLE 216 THERMO FISHER SCIENTIFIC INC.: BUSINESS OVERVIEW TABLE 217 F. HOFFMANN-LA ROCHE LTD.: BUSINESS OVERVIEW TABLE 218 DANAHER CORPORATION: BUSINESS OVERVIEW TABLE 219 QIAGEN N.V.: BUSINESS OVERVIEW TABLE 220 AGILENT TECHNOLOGIES, INC.: BUSINESS OVERVIEW TABLE 221 PERKINELMER INC.: BUSINESS OVERVIEW TABLE 222 BIO-RAD LABORATORIES, INC.: BUSINESS OVERVIEW TABLE 223 EUROFINS SCIENTIFIC: BUSINESS OVERVIEW TABLE 224 PACIFIC BIOSCIENCES: BUSINESS OVERVIEW TABLE 225 OXFORD NANOPORE TECHNOLOGIES PLC: BUSINESS OVERVIEW TABLE 226 TAKARA BIO INC.: BUSINESS OVERVIEW TABLE 227 BGI GROUP: BUSINESS OVERVIEW TABLE 228 EPPENDORF AG: BUSINESS OVERVIEW TABLE 229 MERCK KGAA: BUSINESS OVERVIEW TABLE 230 BECTON, DICKINSON AND COMPANY: BUSINESS OVERVIEW TABLE 231 ABBOTT LABORATORIES: BUSINESS OVERVIEW TABLE 232 23ANDME, INC.: BUSINESS OVERVIEW TABLE 233 10X GENOMICS: BUSINESS OVERVIEW TABLE 234 NEW ENGLAND BIOLABS: BUSINESS OVERVIEW TABLE 235 PROMEGA CORPORATION: BUSINESS OVERVIEW TABLE 236 CREATIVE BIOGENE: BUSINESS OVERVIEW TABLE 237 NOVOGENE CO., LTD.: BUSINESS OVERVIEW TABLE 238 ULTIMA GENOMICS, INC. BUSINESS OVERVIEW TABLE 239 FREENOME HOLDINGS, INC.: BUSINESS OVERVIEW
FIGURE 1 RESEARCH DESIGN FIGURE 2 GENOMICS MARKET: PRIMARY RESPONDENTS FIGURE 3 GENOMICS MARKET SIZE ESTIMATION: SUPPLY-SIDE ANALYSIS FIGURE 4 MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ANALYSIS-BASED ESTIMATION) FIGURE 5 MARKET SIZE VALIDATION FROM PRIMARY SOURCES FIGURE 6 GENOMICS MARKET: CAGR PROJECTIONS FIGURE 7 GENOMICS MARKET: GROWTH ANALYSIS OF DEMAND-SIDE FACTORS FIGURE 8 DATA TRIANGULATION METHODOLOGY FIGURE 9 GENOMICS MARKET, BY PRODUCT & SERVICE, 2023 VS. 2028 (USD MILLION) FIGURE 10 GENOMICS MARKET, BY TECHNOLOGY, 2023 VS. 2028 (USD MILLION) FIGURE 11 GENOMICS MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION) FIGURE 12 GENOMICS MARKET, BY END USER, 2023 VS. 2028 (USD MILLION) FIGURE 13 GEOGRAPHICAL SNAPSHOT OF GENOMICS MARKET FIGURE 14 RISING PREVALENCE OF GENETIC DISORDERS TO DRIVE MARKET FIGURE 15 CONSUMABLES AND REAGENTS ACCOUNTED FOR LARGEST MARKET SHARE IN 2022 FIGURE 16 DRUG DISCOVERY AND DEVELOPMENT SEGMENT WILL CONTINUE TO DOMINATE MARKET IN 2028 FIGURE 17 CHINA TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD FIGURE 18 GENOMICS MARKET: DRIVERS, OPPORTUNITIES, CHALLENGES, AND TRENDS FIGURE 19 BURDEN OF HIV INFECTIONS, BY REGION, 2021 FIGURE 20 VALUE CHAIN ANALYSIS-MAXIMUM VALUE ADDED DURING SEQUENCING AND ANALYSIS PHASES FIGURE 21 ECOSYSTEM ANALYSIS OF GENOMICS MARKET FIGURE 22 REVENUE SHIFT AND NEW REVENUE POCKETS FIGURE 23 GENOME SEQUENCING PRICING TREND FIGURE 24 PATENT APPLICATIONS FOR GENOMICS (NEXT-GENERATION SEQUENCING) MARKET, JANUARY 2012-MARCH 2023 FIGURE 25 PATENT APPLICATIONS FOR GENOMICS (POLYMERASE CHAIN REACTION) MARKET, JANUARY 2012-MARCH 2023 FIGURE 26 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF GENOMICS PRODUCTS AND SERVICES FIGURE 27 BUYING CRITERIA FOR GENOMICS PRODUCTS FIGURE 28 NORTH AMERICA: GENOMICS MARKET SNAPSHOT FIGURE 29 ASIA PACIFIC: GENOMICS MARKET SNAPSHOT FIGURE 30 GENOMICS MARKET: STRATEGIES ADOPTED BY KEY PLAYERS FIGURE 31 REVENUE ANALYSIS OF KEY COMPANIES, 2020-2022 FIGURE 32 GENOMICS MARKET SHARE ANALYSIS, BY KEY PLAYER, 2022 FIGURE 33 GENOMICS MARKET: COMPANY EVALUATION MATRIX, 2022 FIGURE 34 GENOMICS MARKET: COMPANY EVALUATION MATRIX FOR STARTUPS/SMES, 2022 FIGURE 35 ILLUMINA, INC.: COMPANY SNAPSHOT (2022) FIGURE 36 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2022) FIGURE 37 F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT (2022) FIGURE 38 DANAHER CORPORATION: COMPANY SNAPSHOT (2022) FIGURE 39 QIAGEN N.V.: COMPANY SNAPSHOT (2022) FIGURE 40 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2022) FIGURE 41 PERKINELMER INC.: COMPANY SNAPSHOT (2022) FIGURE 42 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2022) FIGURE 43 EUROFINS SCIENTIFIC: COMPANY SNAPSHOT (2022) FIGURE 44 PACIFIC BIOSCIENCES: COMPANY SNAPSHOT (2022) FIGURE 45 OXFORD NANOPORE TECHNOLOGIES PLC: COMPANY SNAPSHOT (2022) FIGURE 46 TAKARA BIO INC.: COMPANY SNAPSHOT (2022) FIGURE 47 EPPENDORF AG: COMPANY SNAPSHOT (2021) FIGURE 48 MERCK KGAA: COMPANY SNAPSHOT (2022) FIGURE 49 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2022) FIGURE 50 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2022) FIGURE 51 23ANDME, INC.: COMPANY SNAPSHOT (2021) FIGURE 52 10X GENOMICS: COMPANY SNAPSHOT (2022)
